Author

Martin Klammer

Observed name: M. Klammer

Observed institutions: Stockholm University, Evotec (Germany), AlbaNova, Max Planck Institute of Biochemistry

OpenAlex ID: A5023951641

Phosphosignature Predicts Dasatinib Response in Non-small Cell Lung Cancer

2012 · Martin Klammer, Marc Kaminski, et al. · Molecular & Cellular Proteomics · 116

Multicenter evaluation of blood‐based biomarkers for the detection of endometriosis and adenomyosis: A prospective non‐interventional study

2023 · Stefanie Burghaus, Predrag Drazic, et al. · International Journal of Gynecology & Obstetrics · 41

PDF

Identifying differentially regulated subnetworks from phosphoproteomic data

2010 · Martin Klammer, Klaus Godl, et al. · BMC Bioinformatics · 36

PDF

Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist

2012 · Stefan Weigand, Frank Herting, et al. · Cancer Research · 34

Comparison of SILAC and mTRAQ Quantification for Phosphoproteomics on a Quadrupole Orbitrap Mass Spectrometer

2013 · Felix S. Oppermann, Martin Klammer, et al. · Journal of Proteome Research · 33

MetaTM - a consensus method for transmembrane protein topology prediction

2009 · Martin Klammer, David N Messina, et al. · BMC Bioinformatics · 31

PDF

Systematic evaluation of label‐free and super‐SILAC quantification for proteome expression analysis

2015 · Andreas Tebbe, Martin Klammer, et al. · Rapid Communications in Mass Spectrometry · 20

jSquid: a Java applet for graphical on-line network exploration

2008 · Martin Klammer, Sanjit Roopra, et al. · Bioinformatics · 19

PDF

New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study

2020 · Satoshi Yajima, Takashi Suzuki, et al. · Annals of Surgical Oncology · 18

Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma

2022 · Juliane Malik, Martin Klammer, et al. · World Journal of Gastroenterology · 17

Identification of Significant Features by the Global Mean Rank Test

2014 · Martin Klammer, J. Nikolaj Dybowski, et al. · PLoS ONE · 17

Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling

2016 · Sebastian K. Wandinger, Idoya Lahortiga, et al. · PLoS ONE · 16

PDF

Soluble Angiotensin-Converting Enzyme 2 as a Prognostic Biomarker for Disease Progression in Patients Infected with SARS-CoV-2

2022 · Noelia Diaz Troyano, Pablo Gabriel Medina, et al. · Diagnostics · 14

PDF

Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib

2015 · Martin Klammer, J. Nikolaj Dybowski, et al. · PLoS ONE · 10

PDF

Comparative proteome analysis across non-small cell lung cancer cell lines

2015 · Kathrin Grundner-Culemann, J. Nikolaj Dybowski, et al. · Journal of Proteomics · 7

Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial

2019 · Axel Ducret, Ian James, et al. · PLoS ONE · 6

PDF

Global Phosphoproteome Analysis of AML Bone Marrow Reveals Predictive Markers for the Treatment with AC220

2012 · Christoph Schaab, Felix Oppermann, et al. · Blood · 2

Discovery of novel protein biomarkers for the detection of polyendocrine metabolic ovarian syndrome phenotype A

2026 · Johanna Sillman, Annunziata Di Domenico, et al. · Scientific Reports · 1

PDF

Data from Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist